Methods of diagnosing and treating conduct disorder Grant US-11806340-B2 United States of America 07 Nov 2023
Methods of diagnosing and treating anxiety disorder Grant US-11806341-B2 United States of America 07 Nov 2023
Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa… Grant US-11779577-B2 United States of America 10 Oct 2023
Methods of diagnosing and treating ADHD in biomarker positive subjects Grant US-11684617-B2 United States of America 27 Jun 2023
NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR FOR TREATMENT OF 22Q SYNDROME Application EP-4023222-A1 European Patent Office 06 Jul 2022
METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME Application EP-3977996-A1 European Patent Office 06 Apr 2022
METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER Application EP-3964213-A1 European Patent Office 09 Mar 2022
METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER Application EP-3922249-A1 European Patent Office 15 Dec 2021
Methods of diagnosing and treating conduct disorder Grant US-11179378-B2 United States of America 23 Nov 2021
Methods of diagnosing and treating anxiety disorder Grant US-11173153-B2 United States of America 16 Nov 2021
Methods and compositions for improving cognitive function Grant US-11160785-B2 United States of America 02 Nov 2021
Extended release pharmaceutical compositions of levetiracetam Grant US-10925834-B2 United States of America 23 Feb 2021
Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa… Grant US-10918632-B2 United States of America 16 Feb 2021
Nonselective metabotropic glutamate receptor activators for treatment of attention… Grant US-10869861-B2 United States of America 22 Dec 2020
Methods to diagnose and treat attention-deficit, hyperactivity disorder (ADHD) Grant US-10844434-B2 United States of America 24 Nov 2020
Methods and compositions for improving cognitive function Grant US-10806717-B2 United States of America 20 Oct 2020
Methods and compositions for treating schizophrenia Grant US-10624875-B2 United States of America 21 Apr 2020
METHODS OF DIAGNOSING AND TREATING AUTISM Application EP-3307913-A4 European Patent Office 27 Mar 2019
Extended release pharmaceutical compositions of levetiracetam Grant US-10159648-B2 United States of America 25 Dec 2018
Methods and compositions for treating schizophrenia Grant US-10154988-B2 United States of America 18 Dec 2018
USE OF R-OXIRACETAM IN PHARMACEUTICAL FIELD Application US-20180147183-A1 United States of America 31 May 2018
Nonselective metabotropic glutamate receptor activators for treatment of attention… Grant US-9884057-B2 United States of America 06 Feb 2018
METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER Application WO-2017044502-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2017
METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER Application WO-2017044503-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2017
METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME Application WO-2017044497-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2017
NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION… Application WO-2017044491-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2017
METHODS OF DIAGNOSING AND TREATING AUTISM Application WO-2016205348-A1 World Intellectual Property Organisation (WIPO) 22 Dec 2016
4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC… Application US-20140296317-A1 United States of America 02 Oct 2014
(RS)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide compound which exhibits modulatory… Application MD-20140042-A2 Republic of Moldova 30 Sep 2014
Use of piracetam for treating diabetic nephropathy Grant US-8686037-B2 United States of America 01 Apr 2014
Methods and compositions for improving cognitive function Grant US-8604075-B2 United States of America 10 Dec 2013
NEW APPLICATION OF 2-PYRROLIDONE DERIVATIVES Application US-20120258997-A1 United States of America 11 Oct 2012